Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-24-157373
Filing Date
2024-06-07
Accepted
2024-06-07 16:15:54
Documents
13
Period of Report
2024-05-16
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K/A d837500d8ka.htm   iXBRL 8-K/A 25677
  Complete submission text file 0001193125-24-157373.txt   153649

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lyra-20240516.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyra-20240516_lab.xml EX-101.LAB 18685
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyra-20240516_pre.xml EX-101.PRE 11702
16 EXTRACTED XBRL INSTANCE DOCUMENT d837500d8ka_htm.xml XML 4232
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39273 | Film No.: 241029637
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)